News - See what's new!
Find all the latest information on upcoming events, product developments, and company announcements.
![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_26-07-24_RedGreenIndicators.png)
Red and Green Indicators: A New perspective on Glaucoma
In this episode of Dr. Chris Lievens’ The 4-Eyed Professor podcast, he tackles the complexities and misconceptions surrounding red and green indicators.
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_10-06-24_Healio-ASCRS.jpg)
David L. Cooke ASCRS video interview
In this ASCRS Healio Video Perspective, David L. Cooke, MD, describes a challenging case of myopia and astigmatism after cataract surgery.
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews-10-06-24_Analysis-Anterior.png)
Analysis of anterior chamber inflammation
In this video interview at ARVO 2024, Edmund Tsui, MD, presents an overview of his team's research using swept-source OCT with the ANTERION platform to look at anterior chamber cells in patients with uveitis.
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_13-06-24_BringingOCTtoLife.png)
Podcast: Bringing OCT Imaging to Life
Join your host, Chris Lievens, OD, MS, PhD, and guest Jim Williamson, OD, FAAO, as they dive into the facinating world of OCT imaging. Discover the intricacies of OCT technology and journey through the evolution of retinal imaging from the past to the present, while speculating on future directions.
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_ARVO-2024_%20Repeatability-FLIO.png)
ARVO 2024: Repeatability and Reproducibility of FLIO and Erythrocyte Mediated Angiography in a Non-Human Primate Model
In an interview with Ophthalmology Times, Osamah Saeedi, MD, MS, explained the key findings from the poster he presented at the ARVO Imaging in the Eye Conference in Seattle.
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_05-02-24_Glaucoma_280x420_Thumb.jpg)
Early diagnosis, treatment of glaucoma using advanced technology is an ethical obligation
Sanket Shah, MD, explains how OCT imaging is enabling doctors to detect glaucoma in patients at much earlier stages, making the deployment of these advanced technologies an ethical imperative.
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_02-05-24_Whole_picture_280x320_Thumb.jpg)
Getting the Whole Picture
In this case study of a 72-year-old diabetic patient with compromised vision, James Fanelli, OD, highlights the importance of stepping back from micron-level details in OCT interpretations to gain a broader understanding of ocular health
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_29-04-24_Difference-Map_Geographic-Atrophy.jpg)
ENGAGING PATIENTS WITH THEIR AMD CARE
Clinicians are keenly aware of the need to keep patients onboard with treatment and never more so with a condition which shows no real benefit of treatment. Visualisation - black means fluid, and grey means abnormal blood vessels - is the key to ensuring that patients return regularly and engage with sight-saving therapies
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_29-04-24_Difference-Map_Patient-Management.jpg)
PATIENT MANAGEMENT WITH LIMITED RESOURCES
With an array of breakthrough drugs in the pipeline, clinicians are being urged to upskill and healthcare managers should prepare patient pathways. Mindful of costs, the price of treatment may be considerably less than residential care for a patient who is no longer able to look after themselves and requires round the clock nursing.
Read more![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2024/eNews_29-04-24_Difference-Patients.jpg)
MAP AND TRACK AMD WITH MACHINE LEARNING AND AI
Causing three times the sight loss of any other ocular morbidity, AMD can be a devastating diagnosis. By using AI to identify the patients with the greatest opportunity for effective treatment, there is a cause for optimism as the enormous benefits of machine learning are put to work.
Read more